152 related articles for article (PubMed ID: 26776160)
1. The E3 ubiquitin protein ligase MDM2 dictates all-trans retinoic acid-induced osteoblastic differentiation of osteosarcoma cells by modulating the degradation of RARα.
Ying M; Zhang L; Zhou Q; Shao X; Cao J; Zhang N; Li W; Zhu H; Yang B; He Q
Oncogene; 2016 Aug; 35(33):4358-67. PubMed ID: 26776160
[TBL] [Abstract][Full Text] [Related]
2. E2F1 impairs all-trans retinoic acid-induced osteogenic differentiation of osteosarcoma via promoting ubiquitination-mediated degradation of RARα.
Zhang L; Zhou Q; Zhang N; Li W; Ying M; Ding W; Yang B; He Q
Cell Cycle; 2014; 13(8):1277-87. PubMed ID: 24608861
[TBL] [Abstract][Full Text] [Related]
3. All-trans retinoic acid inhibits tumor growth of human osteosarcoma by activating Smad signaling-induced osteogenic differentiation.
Yang QJ; Zhou LY; Mu YQ; Zhou QX; Luo JY; Cheng L; Deng ZL; He TC; Haydon RC; He BC
Int J Oncol; 2012 Jul; 41(1):153-60. PubMed ID: 22485251
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma.
He BC; Chen L; Zuo GW; Zhang W; Bi Y; Huang J; Wang Y; Jiang W; Luo Q; Shi Q; Zhang BQ; Liu B; Lei X; Luo J; Luo X; Wagner ER; Kim SH; He CJ; Hu Y; Shen J; Zhou Q; Rastegar F; Deng ZL; Luu HH; He TC; Haydon RC
Clin Cancer Res; 2010 Apr; 16(8):2235-45. PubMed ID: 20371684
[TBL] [Abstract][Full Text] [Related]
5. Small ubiquitin-related modifier-1 modification regulates all-trans-retinoic acid-induced differentiation via stabilization of retinoic acid receptor α.
Zhou Q; Zhang L; Chen Z; Zhao P; Ma Y; Yang B; He Q; Ying M
FEBS J; 2014 Jul; 281(13):3032-47. PubMed ID: 24819975
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells.
Fang Y; Zhou X; Lin M; Ying M; Luo P; Zhu D; Lou J; Yang B; He Q
Mol Carcinog; 2011 Jan; 50(1):24-35. PubMed ID: 20945414
[TBL] [Abstract][Full Text] [Related]
7. [All-trans retinoic acid promotes differentiation of human leukemia cells by degrading NLS-RARα].
Li J; Liu B; Ye J; Xiong L; Yu L; Zhong P; Yuan Z; Liu D; Yao J; Liu J; Zhong L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Dec; 35(12):1082-1087. PubMed ID: 31894006
[TBL] [Abstract][Full Text] [Related]
8. Activation of RARα induces autophagy in SKBR3 breast cancer cells and depletion of key autophagy genes enhances ATRA toxicity.
Brigger D; Schläfli AM; Garattini E; Tschan MP
Cell Death Dis; 2015 Aug; 6(8):e1861. PubMed ID: 26313912
[TBL] [Abstract][Full Text] [Related]
9. NLS-RARα Inhibits the Effects of All-trans Retinoic Acid on NB4 Cells by Interacting with P38α MAPK.
Xiao C; Zhong L; Shan Z; Xu T; Gan L; Song H; Yang R; Li L; Liu B
Int J Med Sci; 2016; 13(8):611-9. PubMed ID: 27499693
[TBL] [Abstract][Full Text] [Related]
10. Activation of
Zhang F; Zhu YL; Deng WL; Zhu J; Zhang J
J Leukoc Biol; 2017 Mar; 101(3):655-664. PubMed ID: 27605212
[TBL] [Abstract][Full Text] [Related]
11. A novel SNP in HUWE1 promoter confers increased risk of NOA by affecting the RA/RARα pathway in Chinese individuals.
Shan X; Zhang X; Huang G; Lv J; Ye Z; Jiang C; Jiang X; Cheng J; Lin H; Jiang H; Yue H; Wang Z; Xu W
Andrology; 2024 Feb; 12(2):338-348. PubMed ID: 37290064
[TBL] [Abstract][Full Text] [Related]
12. Expression, protein stability and transcriptional activity of retinoic acid receptors are affected by microtubules interfering agents and all-trans-retinoic acid in primary rat hepatocytes.
Dvorák Z; Vrzal R; Ulrichová J; Macejová D; Ondková S; Brtko J
Mol Cell Endocrinol; 2007 Mar; 267(1-2):89-96. PubMed ID: 17291686
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha.
Gianni' M; Boldetti A; Guarnaccia V; Rambaldi A; Parrella E; Raska I; Rochette-Egly C; Del Sal G; Rustighi A; Terao M; Garattini E
Cancer Res; 2009 Feb; 69(3):1016-26. PubMed ID: 19155306
[TBL] [Abstract][Full Text] [Related]
14. Retinoid-suppressed phosphorylation of RARalpha mediates the differentiation pathway of osteosarcoma cells.
Luo P; Yang X; Ying M; Chaudhry P; Wang A; Shimada H; May WA; Adams GB; Mock D; Triche TJ; He Q; Wu L
Oncogene; 2010 May; 29(19):2772-83. PubMed ID: 20190807
[TBL] [Abstract][Full Text] [Related]
15. Post-translational modification of retinoic acid receptor alpha and its roles in tumor cell differentiation.
Xu A; Zhang N; Cao J; Zhu H; Yang B; He Q; Shao X; Ying M
Biochem Pharmacol; 2020 Jan; 171():113696. PubMed ID: 31726045
[TBL] [Abstract][Full Text] [Related]
16. RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells.
Gianni M; Fratelli M; Bolis M; Kurosaki M; Zanetti A; Paroni G; Rambaldi A; Borleri G; Rochette-Egly C; Terao M; Garattini E
Oncotarget; 2017 Jun; 8(23):37041-37060. PubMed ID: 27419624
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of XAB2 enhances all-trans retinoic acid-induced cellular differentiation in all-trans retinoic acid-sensitive and -resistant cancer cells.
Ohnuma-Ishikawa K; Morio T; Yamada T; Sugawara Y; Ono M; Nagasawa M; Yasuda A; Morimoto C; Ohnuma K; Dang NH; Hosoi H; Verdin E; Mizutani S
Cancer Res; 2007 Feb; 67(3):1019-29. PubMed ID: 17283134
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All-
Paukovcekova S; Valik D; Sterba J; Veselska R
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916897
[TBL] [Abstract][Full Text] [Related]
19. The cleavage product deltaPML-RARalpha contributes to all-trans retinoic acid-mediated differentiation in acute promyelocytic leukemia cells.
Jing Y; Xia L; Lu M; Waxman S
Oncogene; 2003 Jun; 22(26):4083-91. PubMed ID: 12821942
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression.
Centritto F; Paroni G; Bolis M; Garattini SK; Kurosaki M; Barzago MM; Zanetti A; Fisher JN; Scott MF; Pattini L; Lupi M; Ubezio P; Piccotti F; Zambelli A; Rizzo P; Gianni' M; Fratelli M; Terao M; Garattini E
EMBO Mol Med; 2015 Jul; 7(7):950-72. PubMed ID: 25888236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
